Resources
Science
ready to use
Technical documents, practical guidance, and scientific context for teams evaluating or running ModQuant PCR m⁶A.
Product documents
Application note
Publications
FAQs
Product documents
Plan, run, and troubleshoot.
Approved files will be connected to these previews before the production site launches.
User guide
ModQuant PCR m⁶A User Guide
Materials, setup, complete protocol, data analysis, and troubleshooting.
Released · MODUG-001 · Rev A
Open released guide ↗
Product document
Product Specification
Kit formats, input requirements, storage conditions, and workflow summary.
24 & 48 reactions · Current
Open specification ↗
Technical note
Assay Development Note
Assay-development context and a representative METTL3 inhibition research use case, pending public claims approval.
Website preview · claims review pending
Review application note →
WEB
Buying guide
Kit Selection Guide
A concise comparison of the 24- and 48-reaction formats and compatible magnets.
1 page · Quick reference
Compare formats →
Scientific insights
Released evidence and scientific context.
Published milestones link to their original source. Forward-looking research concepts are labeled separately.
Company profile · June 2026
From Brown University to the Bench
Brown University profiles Lilac as an outgrowth of the Giuliani RNA Center and its work to make RNA analysis more accessible.
Read the Brown profile ↗
Research perspective · 5 min
Why “Where” Matters as Much as “How Much”
A perspective on site-specific context and the value of adding modification information to RNA studies.
Explore the science →
Methods · 4 min
The Sample-Size Problem in RNA Modification Research
How input requirements can influence which biological questions become practical to pursue.
See the low-input workflow →
Application note preview · claims review pending
Detecting an m⁶A response to METTL3 inhibition.
A website-ready structure for an assay-development story. The scientific and legal teams should review the final data, figures, statistical treatment, and claims before public release.
See the application pathway →
Representative assay-development study
Internal evidence structure
Model
HEK293T cells
Perturbation
STM-2457 treatment for 24 hours
Design
Three separate treatment experiments with poly-A enriched mRNA
ModQuant readout
Relative m⁶A response across treatment conditions
Orthogonal context
LC-MS/MS used in internal assay-development validation
Website status
Concept preview only; public claims approval pending
Open the released protocol ↗ Research Use Only · not a diagnostic or clinical claim
Publications
Evidence library.
Peer-reviewed work is presented with its publication type, release date, DOI, and direct source so the evidence is easy to verify.
Clinical review · Frontiers in Pain Research · Published 16 July 2026
New insight into RNA biomarkers in neuropathic pain: a clinician–neuroscientist roadmap to translational testing and treatment monitoring
This peer-reviewed review maps candidate RNA biomarker classes and translational testing questions. It is scientific context—not a clinical trial or a validated diagnostic claim.
Read the publication ↗
Frequently asked questions
Start with the essentials.
The workflow is designed for relative m⁶A quantification across samples or conditions using a qPCR readout.
The current product guidance specifies 1–10 ng of endogenous mRNA input.
A standard real-time PCR instrument is used for the final readout. Refer to the approved user guide for complete equipment requirements.
The 24-reaction kit supports pilots and focused sets; the 48-reaction kit offers more room for cohorts and repeat studies.
No. ModQuant products shown here are for Research Use Only and are not for use in diagnostic procedures.
Still have a question?